LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diabetes Prevalence Increased in Hospitalized Patients

By LabMedica International staff writers
Posted on 08 Sep 2017
The prevalence of diabetes is increasing in Germany and at present, the metabolic disease affects almost one in ten individuals. It is known that people with diabetes are found more often among hospitalized or intensive care units (ICU) patients than among the general population.

In fact hardly any data are available on the prevalence of diabetes in hospitals. Therefore, scientists have assessed the diabetes prevalence, proportion of undiagnosed cases, the effectiveness of diabetes screening in a university hospital, the consequences for hospital stay and acquired complications.

Scientists at the University Hospital Tȕbingen (Tübingen Germany) screened 3,733 adult patients in Tübingen University Hospital for diabetes and prediabetes over a period of four weeks where blood samples were available. Diabetes diagnosis was defined as HbA1c equal to or greater than 6.5% and/or previously documented diabetes diagnosis; prediabetes was defined as HbA1c equal to or less than 5.7% and less than 6.5% without history of previous diabetes.

The result of the screening was that almost every fourth hospital patient suffered from diabetes (22%) that had a long-term blood glucose level (HbA1c value) of 6.5 % or higher. 24% of the patients in the study had a long-term blood glucose value between 5.7% and 6.4%. These values indicate an early stage of diabetes (prediabetes). Nearly 4% of the investigated patients had undiagnosed diabetes. The study also showed that patients with diabetes required treatment in the hospital approximately 1.47 days longer than patients with the same diagnosis without diabetes or prediabetes. The affected patients also had a higher risk of complications: 24% of the patients with diabetes experienced complications. In comparison, only 15% of the patients without diabetes were affected by complications.

The authors concluded that every fourth patient in the university hospital had diabetes and every second had either prediabetes or diabetes. It is also worthwhile to screen for unknown diabetes in patients over the age of 50. The high prevalence and negative consequences of diabetes require-screening and intensified specialized diabetes treatment in hospitals. The prevalence of hospital-acquired complications was higher in diabetic patients 197 of 630 compared with no diabetes: 447 of 2,459. The study was published on July 27, 2017, in the journal Experimental and Clinical Endocrinology & Diabetes.

Related Links:
University Hospital Tȕbingen

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Gold Member
Hybrid Pipette
SWITCH

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more